As Figure 2 shows, FAM83A expression was significantly elevated in patients with advanced lung cancer (p = 0.02 and p < 0.001 for stage I vs. stages II and III + IV, respectively), lymph node metastasis (p = 0.03 and p < 0.001 for N0 vs. N1 and >N2, respectively) and large tumor size (p < 0.001 and p < 0.001 for T1 vs. T2 and T3 + T4, respectively). The gene discussed is SACK1A; the disease is metastatic malignant neoplasm in the lymph nodes.